- Advertisement -
Image source: Getty Images
From pharmaceutical stocks to dividend-payers, these are the ASX shares that have caught my eye this week.
Mesoblast is a clinical-stage biotech company which develops and commercialises allogeneic cellular medicines to treat complex diseases. Its FDA-approved…
